0.56
+0.01(+1.82%)
Currency In CAD
Sector
Healthcare
Industry
Biotechnology
Employees
N/A
First IPO Date
January 07, 2008
| Name | Title | Pay | Year Born |
| Mr. Francis Gleeson B.B.A. M.B.A | Co-Founder, Chief Executive Officer, President & Director | 267,788 | 1955 |
| Mr. Michael Liggett B.Sc., Bsc. Pharm., C.A., C.P.A., CA, CPA | Strategic Advisor | 44,483 | 1960 |
| Mr. Warren Whitehead C.M.A., CPA | Head of Corporate Strategy | 120,000 | 1952 |
| Dr. Michael A. Rudnicki Ph.D. | Co-Founder & Chief Discovery Officer | 120,000 | 1962 |
| Mr. William Wasyl Jarosz | Executive Director | 193,789 | 1956 |
| Mr. J. Robert Hall CFA | Senior Vice President of Finance & Administration | 0 | N/A |
| Ms. Elizabeth Williams CA, CPA | Chief Financial Officer | 0 | 1978 |
Satellos Bioscience Inc., a regenerative medicine company, develops therapeutics to treat degenerative muscle diseases. Its lead program focuses on the development of oral therapeutic drug to correct muscle stem cell polarity and restore the body's innate muscle repair and regeneration process. The company was incorporated in 2012 and is headquartered in Toronto, Canada.